Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	38.19	14.45	10.45
Graham Fair Price	-22.73	7.97	10.32
PEG	834.27	-0.18	0.02
Price/Book	14.51	0.48	0.42
Price/Cash Flow	592.68	-67.52	9.75
Prices/Earnings	94.64	7.67	3.94
Price/Sales	8.85	0.88	0.81
Price/FCF	592.68	-67.52	9.75
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	10.11	0.24	0.22
Operating Margin	-17.49	0.05	0.07
ROA	-40.29	< 0.005	0.01
ROE	0.03	0.02	-41.17
ROIC	0.07	0.01	-80.71
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.06	7.89	-99.18
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.33	-0.13	-62.50
EPS QOQ	2.00	-0.42	-79.17
FCF QOQ	2.18	-1.17	-46.42
Revenue QOQ	-0.03	0.06	114.24
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	114.07	114.71	0.56
Days Sales Outstanding (DSO)	64.59	57.82	-10.49
Inventory Turnover	0.79	0.78	-0.56
Debt/Capitalization	0.33	0.21	-35.96
Quick Ratio	0.68	0.65	-3.58
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13.31	13.41	0.74
Cash	2.00	2.37	18.39
Capex	-0.53	-0.36	32.32
Free Cash Flow	0.57	-0.10	-83.35
Revenue	6.93	7.34	5.98
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.40	1.41	0.30
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.09	6.57	29.18
Naive Interpretation	Member

06 - Financial Health · Weak

Rating